{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:26:51Z","timestamp":1759541211778,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cbi.2017.11.011","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T18:32:59Z","timestamp":1510684379000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neutrophil depletion protects against zomepirac-induced acute kidney injury in mice"],"prefix":"10.1016","volume":"279","author":[{"given":"Shohei","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-601X","authenticated-orcid":false,"given":"Shingo","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2017.11.011_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/jat.3277","article-title":"Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs","volume":"36","author":"Gomez-Lechon","year":"2016","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2017.11.011_bib2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","article-title":"Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives","volume":"146","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2017.11.011_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2017.11.011_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999","volume":"35","author":"Fung","year":"2001","journal-title":"Drug Inf. J."},{"key":"10.1016\/j.cbi.2017.11.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007691-200302000-00001","article-title":"Acyl glucuronide drug metabolites: toxicological and analytical implications","volume":"25","author":"Shipkova","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cbi.2017.11.011_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-2797(03)00020-6","article-title":"Acyl glucuronide reactivity in perspective: biological consequences","volume":"145","author":"Bailey","year":"2003","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2017.11.011_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0090-9556(25)08612-X","article-title":"Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism","volume":"18","author":"Smith","year":"1990","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2017.11.011_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/dmd.110.035600","article-title":"Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes","volume":"39","author":"Koga","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2017.11.011_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archinte.1983.00350060095015","article-title":"Zomepirac-induced renal failure","volume":"143","author":"Miller","year":"1983","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cbi.2017.11.011_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.1982.03320330068031","article-title":"Anaphylactic shock, acute renal failure, and disseminated intravascular coagulation. Suspected complications of zomepirac","volume":"247","author":"Smith","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2017.11.011_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/j.1552-4604.1982.tb02637.x","article-title":"Disposition of zomepirac sodium in man","volume":"22","author":"O'Neill","year":"1982","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2017.11.011_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0090-9556(25)00283-1","article-title":"The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man","volume":"8","author":"Grindel","year":"1980","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2017.11.011_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dmpk.2014.12.001","article-title":"A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development","volume":"30","author":"Oda","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cbi.2017.11.011_bib14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1124\/dmd.31.11.1429","article-title":"Identification of zomepirac-S-acyl-glutathione in vitro in incubations with rat hepatocytes and in vivo in rat bile","volume":"31","author":"Grillo","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2017.11.011_bib15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.116.069575","article-title":"Zomepirac acyl glucuronide is responsible for zomepirac-induced acute kidney injury in mice","volume":"44","author":"Iwamura","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2017.11.011_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tiv.2015.10.013","article-title":"Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays","volume":"30","author":"Iwamura","year":"2015","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2017.11.011_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00858535","article-title":"Relapse of nephrotic syndrome, progressive renal failure and return to chronic dialysis therapy after a renal transplant","volume":"3","author":"Cameron","year":"1989","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cbi.2017.11.011_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.etp.2015.11.003","article-title":"Immunophenotypical characterization and influence on liver homeostasis of depleting and repopulating hepatic macrophages in rats injected with clodronate","volume":"68","author":"Pervin","year":"2016","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.cbi.2017.11.011_bib19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/S0002-9440(10)63065-9","article-title":"Neutralization of Gro\u03b1 and macrophage inflammatory protein-2 attenuates renal ischemia\/reperfusion injury","volume":"159","author":"Miura","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2017.11.011_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jat.3388","article-title":"Toxicological role of an acyl glucuronide metabolite in diclofenac-induced acute liver injury in mice","volume":"37","author":"Oda","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2017.11.011_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cbi.2017.11.011_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2017.11.011_bib23","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ki.2008.500","article-title":"The chemokine receptors CCR2 and CX3CR1 mediate monocyte\/macrophage trafficking in kidney ischemia-reperfusion injury","volume":"74","author":"Li","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2017.11.011_bib24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ki.2012.207","article-title":"Macrophage\/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia\/reperfusion injury in mice","volume":"82","author":"Ferenbach","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2017.11.011_bib25","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/eji.200939389","article-title":"Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control","volume":"39","author":"Fink","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cbi.2017.11.011_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/hep.510290324","article-title":"Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule-1 expression in the liver during acute endotoxemia in rats","volume":"29","author":"Ahmad","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2017.11.011_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0167-4838(00)00152-7","article-title":"Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse","volume":"1482","author":"Kjeldsen","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2017.11.011_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1440-1797.2010.01317.x","article-title":"Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury","volume":"15","author":"Devarajan","year":"2010","journal-title":"Nephrol. Carlt."},{"key":"10.1016\/j.cbi.2017.11.011_bib29","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","volume":"14","author":"Mishra","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2017.11.011_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dmpk.2016.11.002","article-title":"Toxicological potential of acyl glucuronides and its assessment","volume":"32","author":"Iwamura","year":"2017","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cbi.2017.11.011_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2165\/00002018-199512020-00004","article-title":"Tenoxicam and renal function","volume":"12","author":"Heintz","year":"1995","journal-title":"Drug Saf."},{"key":"10.1016\/j.cbi.2017.11.011_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0009-2797(98)00071-4","article-title":"Zomepirac acyl glucuronide covalently modifies tubulin in vitro and in vivo and inhibits its assembly in an in vitro system","volume":"115","author":"Bailey","year":"1998","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2017.11.011_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0024-3205(00)00981-4","article-title":"Dipeptidyl peptidase IV is a target for covalent adduct formation with the acyl glucuronide metabolite of the anti-inflammatory drug zomepirac","volume":"68","author":"Wang","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2017.11.011_bib34","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1124\/dmd.110.034173","article-title":"Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide","volume":"38","author":"Sawamura","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2017.11.011_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/clpt.1985.146","article-title":"Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac","volume":"38","author":"Smith","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2017.11.011_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cbi.2017.11.011_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2017.11.011_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.107.119792","article-title":"Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1\u03b2, IL-18, IL-6, and neutrophil infiltration in the kidney","volume":"322","author":"Faubel","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2017.11.011_bib39","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2017.11.011_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules","volume":"81","author":"Foell","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cbi.2017.11.011_bib41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.smim.2013.10.005","article-title":"Interleukin-1\u03b1","volume":"25","author":"Rider","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cbi.2017.11.011_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2017.11.011_bib43","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ni.3503","article-title":"Interleukin 1\u03b1 and the inflammatory process","volume":"17","author":"Di Paolo","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cbi.2017.11.011_bib44","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.4049\/jimmunol.181.12.8194","article-title":"Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1\u03b1 released from dying cells","volume":"181","author":"Eigenbrod","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cbi.2017.11.011_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF01560700","article-title":"Interleukin-1 treatment increases neutrophils but not antioxidant enzyme activity or resistance to ischemia-reperfusion injury in rat kidneys","volume":"18","author":"Guidot","year":"1994","journal-title":"Inflammation"},{"year":"2016","author":"Food and Drug Administration","series-title":"Safety Testing of Drug Metabolites. Safety Testing of Drug Metabolites Guidance for Industry","key":"10.1016\/j.cbi.2017.11.011_bib46"},{"key":"10.1016\/j.cbi.2017.11.011_bib47","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1248\/bpb.b13-00329","article-title":"A simple method to evaluate reactivity of acylglucuronides optimized for early stage drug discovery","volume":"36","author":"Jinno","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cbi.2017.11.011_bib48","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/tx049900+","article-title":"A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC\/MS\/MS measurements","volume":"17","author":"Wang","year":"2004","journal-title":"Chem. Res. Toxicol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717309729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717309729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:46:33Z","timestamp":1757857593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717309729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"alternative-id":["S0009279717309729"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.11.011","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil depletion protects against zomepirac-induced acute kidney injury in mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}